Literature DB >> 23849332

Trends in the antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006-2010.

Hsih-Yeh Tsai1, Yen-Hsu Chen, Chun-Hsing Liao, Po-Liang Lu, Cheng-Hua Huang, Chin-Te Lu, Yin-Ching Chuang, Shih-Ming Tsao, Yao-Shen Chen, Yung-Ching Liu, Wei-Yu Chen, Tsrang-Neng Jang, Hsiu-Chen Lin, Chih-Ming Chen, Zhi-Yuan Shi, Sung-Ching Pan, Jia-Ling Yang, Hsiang-Chi Kung, Chun-Eng Liu, Yu-Jen Cheng, Jien-Wei Liu, Wu Sun, Lih-Shinn Wang, Wen-Chien Ko, Kwok-Woon Yu, Ping-Cherng Chiang, Ming-Hsun Lee, Chun-Ming Lee, Gwo-Jong Hsu, Po-Ren Hsueh.   

Abstract

Isolates of Streptococcus pneumoniae (n = 530) were collected from 20 hospitals in different parts of Taiwan from 2006 to 2010. MICs to 16 antimicrobial agents were determined by broth dilution method and serotypes were identified by latex agglutination. Based on meningitis (non-meningitis) criteria established by the CLSI, 11.7% (63.2%) of all isolates were susceptible to penicillin and 46.0% (83.8%) were susceptible to ceftriaxone. Of the isolates, 94.3% were non-susceptible to azithromycin and 5.8% and 7.2% were non-susceptible to moxifloxacin and levofloxacin, respectively. Susceptibility to penicillin by meningitis criteria increased significantly (P = 0.0012) with year, and that to clindamycin and amoxicillin/clavulanic acid declined significantly (P < 0.05). Six major serotypes were found, namely 19F (24.0%), 23F (18.5%), 14 (13.6%), 6B (12.5%), 19A (7.5%) and 3 (5.1%). Prevalence of serotypes 19F and 14 remained stationary, that of serotype 6B decreased significantly (P < 0.0001) and that of serotype 19A increased significantly (P < 0.0001) with year. The coverage rate of PCV-7 among the pneumococcal isolates declined from 80.5% in 2006 to 50% in 2010 (P < 0.0001) and that of PCV-13 declined from 91.5% in 2009 to 75% in 2010. The non-susceptibility rate to levofloxacin was highest among serotype 23F isolates (13.3%) and lowest among serotype 19A isolates (2.5%). Rates of resistance to the four agents penicillin, ceftriaxone, azithromycin and clindamycin were highest among serotype 19A isolates (70.0%) and 23F isolates (49.0%). All serotype 3 isolates were susceptible to four of the most commonly used antibiotics (penicillin, ceftriaxone, azithromycin and levofloxacin).
Copyright © 2013 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Keywords:  Antimicrobial susceptibility; Serotypes; Streptococcus pneumoniae; TIST; Taiwan

Mesh:

Substances:

Year:  2013        PMID: 23849332     DOI: 10.1016/j.ijantimicag.2013.05.013

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  5 in total

1.  Changing trends in serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive diseases in Central Thailand, 2009-2012.

Authors:  Wanatpreeya Phongsamart; Somporn Srifeungfung; Tanittha Chatsuwan; Pongpun Nunthapisud; Vipa Treerauthaweeraphong; Pimpha Rungnobhakhun; Sirintip Sricharoenchai; Kulkanya Chokephaibulkit
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 2.  Pneumococcal disease and use of pneumococcal vaccines in Taiwan.

Authors:  Sung-Hsi Wei; Chuen-Sheue Chiang; Chyi-Liang Chen; Cheng-Hsun Chiu
Journal:  Clin Exp Vaccine Res       Date:  2015-07-29

3.  Increase in the rate of azithromycin-resistant Streptococcus pneumoniae isolates carrying the erm(B) and mef(A) genes in Taiwan, 2006-2010.

Authors:  Dodi Safari; Lu-Cheng Kuo; Yu-Tsung Huang; Chun-Hsing Liao; Wang-Huei Sheng; Po-Ren Hsueh
Journal:  BMC Infect Dis       Date:  2014-12-19       Impact factor: 3.090

4.  Decline in the incidence of invasive pneumococcal disease at a medical center in Taiwan, 2000-2012.

Authors:  Chih-Cheng Lai; Sheng-Hsiang Lin; Chun-Hsing Liao; Wang-Huei Sheng; Po-Ren Hsueh
Journal:  BMC Infect Dis       Date:  2014-02-11       Impact factor: 3.090

5.  Comparative Treatment Failure Rates of Respiratory Fluoroquinolones or β-Lactam + Macrolide Versus β-Lactam Alone in the Treatment for Community-Acquired Pneumonia in Adult Outpatients: An Analysis of a Nationally Representative Claims Database.

Authors:  Meng-Tse Gabriel Lee; Shih-Hao Lee; Shy-Shin Chang; Ya-Lan Chan; Laura Pang; Sue-Ming Hsu; Chien-Chang Lee
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.